Defunct Company
Total Trials
4
As Lead Sponsor
0
As Collaborator
Total Enrollment
186
NCT02065882
Pharmacokinetic, Efficacy and Safety of BT524 in Patients With Congenital Fibrinogen Deficiency
Phase: Phase 3
Role: Collaborator
Start: Mar 31, 2013
Completion: Nov 18, 2020
NCT03480230
Neoadjuvant Compound 121564 Plus Platinum Doublet Chemotherapy in Non-Small Cell Lung Cancer
Phase: Phase 2
Start: Jun 26, 2018
Completion: Nov 30, 2022
NCT03503630
Short-course Radiation Followed by mFOLFOX-6 Plus COMPOUND 2055269 for Locally-advanced Rectal Adenocarcinoma
Start: Jul 20, 2018
Completion: Jul 2, 2024
NCT04763759
Study to Evaluate Safety and Activity of TRL1068 in Prosthetic Joint Infections
Phase: Phase 1
Start: Feb 8, 2021
Completion: Mar 13, 2024